SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-10-045995
Filing Date
2010-08-23
Accepted
2010-08-23 08:58:28
Documents
3
Period of Report
2010-09-17
Effectiveness Date
2010-08-23

Document Format Files

Seq Description Document Type Size
1 v194764_def14a.htm DEF 14A 253938
2 GRAPHIC proxypg01.jpg GRAPHIC 214924
3 GRAPHIC proxypg02.jpg GRAPHIC 116905
  Complete submission text file 0001144204-10-045995.txt   712894
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 101031365
SIC: 2834 Pharmaceutical Preparations